Skip to main content
SpringerLink
Log in

Dermatika

  • Chapter
Arzneiverordnungs-Report 2015

  • 1942 Accesses

Zusammenfassung

Die Verordnungen von Dermatika halten sich seit Jahren auf stabilem Niveau. Am häufigsten werden Corticosteroide verordnet. Auf sie entfällt 2014 wie bereits im Vorjahr fast die Hälfte der verordneten Tagesdosen aller Dermatika. Deutlich seltener verordnet werden dermatologische Antimykotika (13%), Aknemittel (8%), Psoriasismittel (7%), Antiinfektiva (4%), Warzenmittel (5%) und Wundbehandlungsmittel (6%). Die übrigen Gruppen hatten im vergangenen Jahr zusammen einen Verordnungsanteil von etwa 10%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AlsterholmM,FlytströmI,BergbrantIM,FaergemannJ(2010):Fusidicacid-resistantStaphylo-coccusaureusinimpetigocontagiosaandsecondarilyinfectedatopicdermatitis.ActaDermVenereol90:52–57

    Google Scholar 

  • AlstonSJ,CohenBA,BraunM(2003):Persistentandrecurrenttineacorporisinchildrentreatedwithcombinationantifungal/corticosteroidagents.Pediatrics111:201–203

    Article  PubMed  Google Scholar 

  • AltmeyerPJ,MatthesU,PawlakF,HoffmannK,FroschPJ,RuppertPetal.(1994):Antipsoriaticeffectoffumaricacidderivatives.Resultsofamulticenterdouble-blindstudyin100pa-tients.JAmAcadDermatol30:977–981

    CAS  Google Scholar 

  • Anonymus(2002):Newtreatmentsforactinickeratoses.MedicalLetter44:57–58

    Google Scholar 

  • AntilleC,SauratJH,LübbeJ(2004):Inductionofrosaceiformdermatitisduringtreatmentoffacialinflammatorydermatoseswithtacrolimusointment.ArchDermatol140:457–460

    Google Scholar 

  • AricanO,SasmazS,OzbuluO(2006):Increasedsuicidaltendencyinacaseofpsoriasisvulgarisunderacitretintreatment.JEurAcadDermatolVenerol20:464–465

    CAS  Google Scholar 

  • ArzneimittelkommissionderdeutschenÄrzteschaft(1999):NutzenundRisikendurchFumarsäure-EsterbeiderTherapiederPsoriasis.DtschÄrztebl96:A–721

    Google Scholar 

  • ArzneimittelkommissionderdeutschenÄrzteschaft(2005):MyopathienachTacrolimus-Salbe(Protopic).DtschÄrztebl102:A313–8

    Google Scholar 

  • ArzneimittelkommissionderdeutschenÄrzteschaft(2006):PsychiatrischeReaktionennachTerninafin(Lamisil).DtschÄrztebl103:A3432ArzneimittelkommissionderdeutschenÄrzteschaft(2011):MultipleaktinischeKeratosen(CarcinomatainsituderHaut)nachlangjährigertopischerAnwendungvonTacrolimus(Protopic).DtschÄrztebl108:A545–A546

    Google Scholar 

  • ArzneimittelkommissionderdeutschenÄrzteschaft(2013a):RhabdomyolysenachIsotretinoin.DtschÄrztebl110:A240

    Google Scholar 

  • ArzneimittelkommissionderdeutschenÄrzteschaft(2013b):NokardiosebeiLymphopeniedurchFumaderm(AusderUAW-Datenbank).DtschÄrztebl110:A1220–1221

    Google Scholar 

  • AzizZ,AbuSF,ChongNJ(2012):Asystematicreviewofsilver-containingdressingsandtopicalsilveragents(usedwithdressings)forburnwounds.Burns38:307–318

    Article  CAS  PubMed  Google Scholar 

  • BalakDM,OostveenAM,BousemaMT,VenemaAW,ArnoldWP,SeygerMM,ThioHB(2013):Effectivenessandsafetyoffumaricacidestersinchildrenwithpsoriasis:aretrospectiveanalysisof14patientsfromTheNetherlands.BrJDermatol168:1343–1347

    CAS  Google Scholar 

  • BaranR,KaoukhovA(2005):Topicalantifungaldrugsforthetreatmentofonychomycosis:anoverviewofcurrentstrategiesformonotherapyandcombinationtherapy.JEurAcadDermatolVenerol19:21–29

    CAS  Google Scholar 

  • BarkerJNWN(2011):Methotrexateorfumarates:whichisthebestoraltreatmentforpsoriasis?BrJDermatol164:69–5

    Google Scholar 

  • Bell-SyerSEM,KhanSM,TorgersonDJ(2012):Oraltreatmentsforfungalinfectionsoftheskinofthefoot.CochraneDatabaseofSystematicReviews2012,Issue10.Art.No.:CD003584.DOI:10.1002/14651858.CD003584.pub2

    Google Scholar 

  • Berth-JonesJ,DamstraRJ,GolschS,LivdenJK,VanHooteghemO,AllegraF,ParkerCA.MultinationalStudyGroup(2003):Twiceweeklyfluticasonepropionateaddedtoemollientmain-tenancetreatmenttoreduceriskofrelapseinatopicdermatitis:randomised,doubleblind,parallelgroupstudy.BritMedJ326:1367–1373

    CAS  Google Scholar 

  • BewleyAfortheDermatologyWorkingGroup(2008):Expertconsensus:timeforachangeinthewayweadviseourpatientstousetopicalcorticosteroids.BrJDermatol158:917–920

    Google Scholar 

  • BiogenIdecGmbH(2013):WichtigeHinweiseanmedizinischeFachkreise:Fumaderminitial/>Fumaderm - Vermeidung des Risikos opportunistischer Infektionen durch Einhaltung regelmäßiger Laborkontrollen und weiterer Warnhinweise während der Therapie. http://www.akdae.de/Arzneimittelsicherheit/RHB/20130625.pdf

  • Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke W-H (2003): Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis 49: 80–84

    Article  CAS  PubMed  Google Scholar 

  • Boguniewicz M, Leung DY (2010): Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125: 4–13

    Article  PubMed Central  PubMed  Google Scholar 

  • Booij MT, van De Kerkhof PC (2011): Acitretin revisited in the era of biologics. J Dermatolog Treat 22: 86–89

    Article  PubMed  CAS  Google Scholar 

  • Bradley M, Cullum N, Sheldon T (1999): The debridement of chronic wounds: a systematic review. Health Technol Assess 3: 1–78

    CAS  PubMed  Google Scholar 

  • Braun R (Hrsg.) (2015): Arzneistoff-Profile, Basisinformation über arzneilich wirksame Wirkstoffe. Stammlieferung 1982 mit 1. bis 28. Erg.-Lieferung 2015, Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn

    Google Scholar 

  • Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Landthaler M (2005): Dermatologie und Venerologie, 5. Auflage. Springer Medizin Verlag, Heidelberg Bristow IR, Baran R (2006): Topical and oral combination therapy for toenail onychomycosis. An updated review. J Am Podiatr Med Associat 96: 116–119

    Google Scholar 

  • Brodt HR (2013): Stille - Antibiotikatherapie. Klinik und Praxis der antiinfektiösen Behandlung. 12. Auflage. Schattauer Verlag Stuttgart

    Google Scholar 

  • Bundesinstitut für Arzneimittel und Medizinprodukte (2015): Dimethylfumarathaltige Arzneimittel (Tecfidera, Fumaderm): Progressive multifokale Leuke ncephalopathie (PML) in Zusammenhang mit der Anwendung dimethylfumarathaltiger Arzneimittel, 07.04.2015. http://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2015/RI-dimethylfumarat.html

  • Bundesministerium für Gesundheit (2013): Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII - Beschlüsse über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) - Ingenolmebutat vom: 04.07.2013 Bundesministerium für Gesundheit BAnz AT 01.08.2013 B5 Bundesministerium für Gesundheit und Soziale Sicherung (2004): Bekanntmachung des Gemeinsamen Bundesausschusses über eine Änderung der Richtlinien über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel-Richtlinien) vom 15. Juni 2004. BAnz. Nr. 156 (S. 18 661) vom 20.08.2004, https://www.g-ba.de/institution/sys/>suche/ergebnis/?suche[suchbegriff]=crinohermal & suche[offset]=0 & suche[sortierung]=rel evanz & suche[kategorie]=alle

    Google Scholar 

  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H (2009): Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 7: 759–765

    PubMed  Google Scholar 

  • Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K (2003): Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Manag Care 12: 47–54

    PubMed  Google Scholar 

  • Christiansen B (1988): Untersuchungen über die Wirksamkeit eines Hautdesinfektionsmittels mit kationenaktivem Zusatz. Zbl Bakt Hyg B 186: 368–374

    CAS  Google Scholar 

  • Chroni E, Monastirli A, Tsambaos D (2010): Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf 33: 25–34

    Article  CAS  PubMed  Google Scholar 

  • Chu A, Huber FJ, Plott RT (1997): The comparative efficacy of benzoyl peroxide 5%/erythromy- cin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol; 136: 235–223

    Article  CAS  PubMed  Google Scholar 

  • Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR (2007): Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 6: 495–498

    PubMed  Google Scholar 

  • Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russel I (2002): Oral treatments for toenail onychomycosis. Arch Dermatol 138: 811–816

    Article  CAS  PubMed  Google Scholar 

  • Crawford F, Hollis S (2007): Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007 Jul 18 (3): CD001434 Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R (2012): Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol 53: 6–11

    Google Scholar 

  • Dall'oglio F, D'Amico V, Nasca MR, Micali G (2012): Treatment of cutaneous warts: an evidence- based review. Am J Clin Dermatol 13: 73–96

    Article  PubMed  Google Scholar 

  • Darkes MJM, Scott LJ, Goa KL (2003): Terbinafine. A review of its use in onychomycosis in adults. Am J Clin Dermatol 4: 39–65

    Article  PubMed  Google Scholar 

  • Del Rosso JQ, Pillai R, Moore R (2010): Absence of degradation of tretinoin when benzoyl peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin Aesthet Dermatol 3: 26–28

    PubMed Central  PubMed  Google Scholar 

  • Deutsche Dermatologische Gesellschaft (2011a): Leitlinie zur Therapie der Psoriasis vulgaris - Update 2011. AWMF-Leitlinien-Register Nr. 013/001, http://www.awmf.org/uploads/tx_szleitlinien/013-001l_S3_Psoriasis_vulgaris_Therapie_01.pdf

  • Deutsche Dermatologische Gesellschaft (2011b): Behandlung der Akne. AWMF-Leitlinien- Register Nr. 013/017, http://www.awmf.org/uploads/tx_szleitlinien/013-017l_S2k_Be- handlung_der_Akne_2011-verl%C3%A4ngert.pdf

    Google Scholar 

  • Deutsche Dermatologische Gesellschaft (2011c): Leitlinie zur Behandlung der aktinischen Kera- tose C44.X. AWMF-Leitlinien-Register Nr. 013/041, http://www.awmf.org/uploads/tx_ szleitlinien/013-041l_S1_Aktinische_Keratose_2012-01.pdf

  • Deutsche Dermatologische Gesellschaft (2013): Leitlinie zur Behandlung der Rosazea. AWMF- Leitlinien-Register Nr. 013/065, Entwicklungsstufe S1. http://www.awmf.org/uploads/tx_szleitlinien/013-065l_S1_Rosazea_2014-04.pdf

  • Deutsche Dermatologische Gesellschaft, Deutschsprachige Mykologische Gesellschaft (2008): Tinea der freien Haut. AWMF-Leitlinien-Register Nr. 013-002, http://www.awmf.org/uploads/tx_szleitlinien/013-002-abgelaufen_01.pdf

  • Deutsche Dermatologische Gesellschaft (DDG) et al (2008): Neurodermitis, AWMF-Leitlinien- Register Nr. 013/027 http://www.awmf.org/uploads/tx_szleitlinien/013-027l_S2e_Neuro- dermitis_abgelaufen.pdf

  • Deutsche Gesellschaft für Phlebologie (2008): Diagnostik und Therapie des Ulcus cruris veno- sum. AWMF-Leitlinien-Register Nr. 037/009, http://www.awmf.org/uploads/tx_szleitlinien/037-009l_S3_Diagnostik_und_Therapie_des_Ulcus_cruris_venosum_abgelaufen.pdf

  • Dissemond J, Gerber V, Kramer A, Riepe G, Strobal R, Vasel-Biergans A, Eberlein T (2009): Praxisorientierte Empfehlung zur Behandlung kritisch-kolonisierter und lokal infizierter Wunden mit Polihexanid. Wundmanagement 3: 62–68

    Google Scholar 

  • Dissemond J, Augustin M, Eming SA, Goerge T, Horn T, Karrer S., Schumann H, Stücker M, for the working group for wound healing (AGW) of the German Society of Dermatology (DDG) (2014): Modern wound care - practical aspects of non-interventional topical treatment of patients with chronic wounds. J Dtsch Ges Dermatol, published online: 12 May 2014, DOI: 10.1111/ddg.12351, http://onlinelibrary.wiley.com/doi/10.1111/ddg.12351.pdf

    Google Scholar 

  • Dobie D, Gray J (2004): Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 89: 74–77

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Webster SB, Whitaker DC, Butler B, Lowery BJ, Raimer SA, Krafchik BR, Olsen E, Weston WL (1996): Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol 35: 615–619

    Article  CAS  PubMed  Google Scholar 

  • Dreno B, Bettoli V, Ochsendorf F, Layton AM, Perez M, Dakovic R, Gollnick H (2014): Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallelgroup, phase III studies. Eur J Dermatol; 24: 201–209

    CAS  PubMed  Google Scholar 

  • Drucker CR (2012): Update on topical antibiotics in dermatology. Dermatol Ther 25: 6–11

    Article  PubMed  Google Scholar 

  • Eberlein T, Assadian O (2010): Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination. 23 (Suppl): 45–51

    Google Scholar 

  • Eberlein T, Haemmerle G, Signer M, Gruber Moesenbacher U, Traber J, Mittlboeck M, Abel M, Strohal R (2012): Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. J Wound Care 21: 12–20

    Article  CAS  PubMed  Google Scholar 

  • Ebner F, Heller A, Rippke F, Tausch I (2002): Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3: 427–433

    Article  PubMed  Google Scholar 

  • Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P (2007): Fungal foot infections in patients with diabetes mellitus - results of two independent investigations. Mycoses 50 (Suppl 2): 14–19

    Article  PubMed  Google Scholar 

  • Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Sid- bury R (2014): Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 71: 116–132

    Article  PubMed Central  PubMed  Google Scholar 

  • Eifler-Bollen R, Fluhr JW (2005): Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 56: 752–758

    Article  CAS  PubMed  Google Scholar 

  • El Sayed F, Ammoury A, Dhaybi R, Bazex J (2006): Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol 54: 548–550

    Article  PubMed  Google Scholar 

  • Erbagci Z (2004): Topical therapy for dermatophytoses. Should corticosteroids be included? Am J Clin Dermatol 5: 375–384

    Article  PubMed  Google Scholar 

  • European Medicines Agency (EMA) (2006): European Medicines Agency recommends cautious use of Protopic/Protopy and Elidel. http://www.emea.europa.eu/pdfs/general/direct/pr/9888206en.pdf

  • European Medicines Agency (EMA) (2009): Committee on herbal Medicinal Produkts (HMPC) Assessment report on Hamalmelis virginiana L, Cortex; Hamamelis virginiana L, Folium, Hamamelis virginiana L. Folium et cortex aut ramunculus destillatum. Verfügbar unter http://www.ema.europa.eu/ema/. Letzter Zugriff 30.05.2015

  • European Medicines Agency (EMA) (2014): Committee on herbal Medicinal Produkts (HMPC) Assessment report on Matricaria recutita L., flos and Matricaria recutita L., aetheroleum. Verfügbar unter http://www.ema.europa.eu/ema/. Letzter Zugriff 30.05.2015 Fallah Arani S, Neumann H, Hop WC, Thio HB (2011): Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial. Br J Dermatol 164:855–861

    Google Scholar 

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2010): Topical calcineurin inhibitors: Literature review. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf

  • FDA Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology (2011): Topical calcineurin inhibitors: Literature review addendum. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255140.pdf

  • Ference JD, Last AR (2009): Choosing topical corticosteroids. Am Fam Physician 79: 135–140

    PubMed  Google Scholar 

  • Fleischer AB jr, Abramovits W, Breneman D, Jaracz E; US/Canada tacrolimus ointment study group (2007): Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treat 18: 151–157

    Article  CAS  Google Scholar 

  • Fluhr JW, Cavallotti C, Berardesca E (2008): Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol 26: 380–386

    Article  PubMed  Google Scholar 

  • Fluhr JW, Degitz K (2010): Antibiotika, Azelainsäure und Benzoylperoxid in der topische Aknetherapie. J Dtsch Dermatol Ges 8 (Suppl 1): S24–30

    PubMed  Google Scholar 

  • Fölster-Holst R, Latussek E (2007): Synthetic tannins in dermatology - a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24: 296–301

    Article  PubMed  Google Scholar 

  • Food and Drug Adminstration (2014): FDA warns of rare but serious hypersensitivity reactions with certain over-the-counter topical acne products. http://www.fda.gov/downloads/>Drugs/DrugSafety/UCM402663.pdf

  • Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M; Brimonidine Phase II Study Group (2012): Once-daily topical brimonidine tartrate gel 0-5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol; 166: 633–641

    Article  CAS  Google Scholar 

  • Fowler JF, Graff O, Hamedani AG (2014): A phase 3, randomized, double-blind, placebo-con- trolled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy. J Drugs Dermatol; 13: 1198–1204

    CAS  PubMed  Google Scholar 

  • Frankel HC, Qureshi AA (2012): Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Am J Clin Dermatol 13: 113–123

    Article  PubMed  Google Scholar 

  • Franz T, Vögelin E (2012): Aseptic tissue necrosis and chronic inflammation after irrigation of penetrating hand wounds using Octenisept ■ J Hand Surg Eur 37: 61–64

    Google Scholar 

  • Garnock-Jones KP, Perry CM (2009): Alitretinoin: in severe chronic hand eczema. Drugs 69: 1625–1634

    Article  CAS  PubMed  Google Scholar 

  • Gaspari A, Tyring SK, Rosen T (2009): Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol 8: 467–474

    Google Scholar 

  • Gemeinsamer Bundesausschuss (2015): Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel- Richtlinie/AM-RL) in der Fassung vom 18. Dezember 2008/22. Januar 2009, veröffentlicht im Bundesanzeiger 2009, Nr. 49a, zuletzt geändert am 19. März 2015 veröffentlicht BAnz AT 08.05.2015 B5 in Kraft getreten am 9. Mai 2015 https://www.g-ba.de/informationen/richtlinien/3/

  • Glenn CJ, Kobraei KB, Russo JJ (2011): New-onset psoriasis associated with adalimumab: a report of two cases. Dermatol Online J 17: 1–5

    Google Scholar 

  • Gloor M (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York

    Book  Google Scholar 

  • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J (2002): Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 205: 46–53

    Article  CAS  PubMed  Google Scholar 

  • Goreshi R, Samrao A, Ehst BD (2012): A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene. J Drugs Dermatol; 11: 1422–1426

    CAS  PubMed  Google Scholar 

  • Gorman CR, White SW (2005): Rosaceiform dermatitis as a complication of treatment of facial seborrhoic dermattis with 1% pimecrolimus cream. Arch Dermatol 141: 1168 Griffiths CE, Barker JN (2007): Pathogenesis and clinical features of psoriasis. Lancet 370: 263–271

    Google Scholar 

  • Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S, Dooley LT, Goldstein NH, Menter A; ACCEPT Study Group (2010): Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med; 362: 11812–8

    Google Scholar 

  • Grillo-Ardila CF, Angel-Müller E, Salazar-Dfaz LC, Gaitän HG, Ruiz-Parra AI, Lethaby A (2014): Imiquimod for anogenital warts in non-immunocompromised adults. Cochrane Database Syst Rev. 2014 Nov 1; 11: CD010389. doi:10.1002/14651858.CD010389.pub2 Grover C, Khurana A (2012): An update on treatment of onychomycosis. Mycoses 55: 541–551

    Google Scholar 

  • Gupta AK, Cherman AM, Tyring SK (2005): Viral and nonviral uses of imiquimod: A review. J Cut Med Surg 8: 338–352

    Article  Google Scholar 

  • Gupta AK, Cooper EA (2008): Update in antifungal therapy of dermatophytosis. Mykopathologia 166: 353–367

    Article  Google Scholar 

  • Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM (2004): Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5: 225–237

    Article  PubMed  Google Scholar 

  • Gupta AK, Paquet M, Villanueva E, Brintnell W (2012): Interventions for actinic keratoses. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD004415. DOI: 10.1002/14651858.CD004415.pub2

    Google Scholar 

  • Hahn C, Röseler S, Fritzsche R, Schneider R, Merk HF (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 28: 81–83

    Article  CAS  PubMed  Google Scholar 

  • Hanke CW, Swanson N, Bruce S, Berman B, Kulp J, Levy S (2011): Complete clearance is sus- tained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream. J Drugs Dermatol 10: 165–170

    PubMed  Google Scholar 

  • Haugh M, Helou S, Boissel JP, Cribier BJ (2002): Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol 147: 118–121

    Article  CAS  PubMed  Google Scholar 

  • Havlickova B, Friedrich M (2008): The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses; 51 Suppl 4: 16–26

    Article  CAS  PubMed  Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013a): Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol 27: 399–410

    Article  CAS  PubMed  Google Scholar 

  • Hendriks AG, Keijsers RR, de Jong EM, Seyger MM, van de Kerkhof PC (2013b): Efficacy and safe- ty of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic Literature review. J Eur Acad Dermatol Venereol 27:931–951

    Article  CAS  PubMed  Google Scholar 

  • Hengge UR, Ruzicka T, Schartz RA, Cork MJ (2006): Adverse effects of topical glucocorticoste- roids. J Am Acad Dermatol 54: 1–15

    Article  PubMed  Google Scholar 

  • Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003): Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149: 363–369

    Article  CAS  PubMed  Google Scholar 

  • Hoffmann R, Happle R (2000): Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 10: 410–417

    CAS  PubMed  Google Scholar 

  • Hornstein OP, Nürnberg E (Hrsg) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York Hube B, Hay R, Brasch J, Veraldi S, Schaller M (2015): Dermatomycoses and inflammation: The adaptive balance between growth, damage, and survival. J Mycol Med; 25: e44-e58 Hund M, Sinkgraven R, Rzany B (2004): Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methanthe- liniumbromid (Vagantin ) bei fokaler Hyperhidrose. J Dtsch Dermatol Ges 2: 343–349

    Google Scholar 

  • lorizzo M, Piraccini BM, Tosti A (2010): Today's treatments options for onychomycosis. J Dtsch Dermatol Ges 8: 875–879

    Google Scholar 

  • Janssen Cilag GmbH (2014): Rote-Hand-Brief: Ustekunimab: Auftreten einer exfoliativen Dermatitis (Erythrodermie) und Exfoliation der Haut. 21. November 2014 Jarvis B, Figgitt DP (2003): Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol 4: 203–213

    Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB (1999): Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topi- cal 5-fluorouracil. Clin Cancer Res 5: 2006–2011

    CAS  PubMed  Google Scholar 

  • Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LWA, Morris AD, Butler CC, Berger M, van der Wouden JC (2012): Interventions for impetigo. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD003261. DOI: 10.1002/14651858.CD003261.pub3

    Google Scholar 

  • Koo JYM (2005): New developments in topical sequential therapy for psoriasis. Skin Therapy Lett 10: 1-4

    Google Scholar 

  • Korting HC (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York Krug M, Oji V, Traupe H, Berneburg M (2009): Ichthyoses - Part 1: Differential diagnosis of vulgar ichthyoses and therapeutic options. J Dtsch Dermatol Ges 7: 511–519

    Google Scholar 

  • Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H (1998): Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 196: 217–222

    Article  PubMed  Google Scholar 

  • Küster W (2006): Ichthyosen: Vorschläge für eine verbesserte Therapie. Dtsch Ärztebl 103: A1684–A1689

    Google Scholar 

  • Kujath P, Michelsen A (2008): Wunden - von der Physiologie zum Verband. Dtsch Ärztebl 105: 239–248

    Google Scholar 

  • Kwok CS, Gibbs S, Bennen C, Holland R, Abbott R (2012): Topical treatments for cutaneous warts, Cochrane Database of Systematic Reviews 2012, Issue 9, Art, No« CD00178L DOr: 10,1002/14651858,CD00178Lpub3

    Google Scholar 

  • Lachapelle JM (2014): A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol 24: 3–9

    CAS  PubMed  Google Scholar 

  • Lakshmi C, Srinivas CR (2012): Hand eczema: An update. Indian J Dermatol Venereol Leprol 78: 569–582

    Article  PubMed  Google Scholar 

  • Langer A, Rogowski W (2009): Systematic review of economic evaluations of human cell-de- rived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research 2009, 9: 115 (doi:10.1186/1472-6963-9-115)

    Google Scholar 

  • Langley RG, Lebwohl M, Krueger GG, Szapary PO, Wasfi Y, Chan D, Hsu MC, You Y, Poulin Y,

    Google Scholar 

  • Korman N, Prinz JC, Reich K; PHOENIX 2 Investigators (2015): Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-se- vere psoriasis: results from the PHOENIX 2 study through 5 years of follow-up. Br J Dermatol; 172: 1371–1383

    Article  PubMed  CAS  Google Scholar 

  • Langner A, Sheehan-Dare R, Layton A (2007): A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol 21: 311–319

    Article  CAS  PubMed  Google Scholar 

  • Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Ägren MS (2007): Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2–16

    Article  PubMed  Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005): Treatment options - development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (suppl 1): 25–33

    Article  PubMed  Google Scholar 

  • Lee S, Selva D, Huilgol SC, Goldberg RA, Leibovitch I (2007): Pharmacological treatments for basal cell carcinoma. Drugs 67: 915–934

    Article  CAS  PubMed  Google Scholar 

  • Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C (2015): Risk of lym- phoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol; 72: 992–1002

    Article  PubMed  Google Scholar 

  • Lohde H, Stahlmann R (Hrsg.) (2004): Nadifloxacin - irrationaler Einsatz eines Fluorchinolons zur lokalen Aknetherapie. Zeitschr Chemother 25: 27–29

    Google Scholar 

  • Lokkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol 35: 1021–1026

    Article  CAS  PubMed  Google Scholar 

  • Longstaff E, von Krogh G (2001): Condyloma eradication: self-therapy with 0.15-0.5% podo- phyllotoxin versus 20-25% podophyllin preparations–an integrated safety assessment. Regul Toxicol Pharmacol 33: 117–137

    Article  CAS  PubMed  Google Scholar 

  • Lopaschuk CR (2013): New approach to managing genital warts. Can Fam Physician 59: 73173–6

    Google Scholar 

  • Luger TA, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, Krutmann J, Niedner R, Röcken M, Ruzicka T, Schwarz T (2004): Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer Index. JDDG 7, Band 2: 629–634

    Google Scholar 

  • Magin P, Sullivan J (2010): Suicide attempts in people taking isotretinoin for acne. Br Med J 341: c5866

    Google Scholar 

  • Mahil SK, Andrews TC, Brierley C, Barker JN, Smith CH (2013): Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the Literature. J Dermatolog Treat 24: 38–49

    Article  PubMed  Google Scholar 

  • Mayser P, Freund V, Budihardja D (2009): Toenail onychomycosis in diabetic patients: issues and managemant. Am J Clin Dermatol 10: 211–220

    Article  PubMed  Google Scholar 

  • McClellan KJ, Noble S (2000): Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1: 191–199

    Article  CAS  PubMed  Google Scholar 

  • McNeil JC, Hulten KG, Kaplan SL, Mason EO (2014): Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother 58: 2878–2883

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Menezes de Padua CA, Schnuch A, Nink K, Pfahlberg A, Uter W (2008): Allergic contact dermatitis to topical drugs - epidemiological risk assessment. Pharmacoepidemiol Drug Saf 17: 813–821

    Article  Google Scholar 

  • Meng Y, Dongmei L, Yanbin P, Jinju F, Meile T, Binzhu L, Xiao H, Ping T, Jianmin L (2014): System- atic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol; 39: 696–707

    Article  CAS  PubMed  Google Scholar 

  • Merk HF (2007): Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 12–18

    Article  CAS  PubMed  Google Scholar 

  • Möhrenschlager M, Seidl HP, Ring J, Abeck D (2005): Pediatric tinea capitis. Recognition and management. Am J Clin Dermatol 6: 203–213

    Article  PubMed  Google Scholar 

  • Moore AY (2009): Clinical applications for topical 5-fluorouracil in the treatment of dermatolog- ical disorders. J Dermatolog Treat 20: 328–335

    Article  PubMed  Google Scholar 

  • Moore ZEH, Cowman S (2013): Wound cleansing for pressure ulcers. Cochrane Database Syst Rev. 2013, Issue 3: CD004983. doi: 10.1002/14651858.CD004983.pub3 Mosti G (2013): Wound care in venous ulcers. Phlebology 28 (Suppl 1): 79–85

    Google Scholar 

  • Müller G, Kramer A (2008): Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Antimicrob Chemother 61: 1281–1287

    Article  CAS  Google Scholar 

  • Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X (2005): Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care 9: R246–R250

    Article  PubMed Central  PubMed  Google Scholar 

  • Naldi L, Griffiths CEM (2005): Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 152: 59761–5

    Article  Google Scholar 

  • Niedner R (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen Niedner R, Ziegenmeyer J (Hrsg) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart Nieuwkamp DJ, Murk JL, van Oosten BW, Cremers CH, Killestein J, Viveen MC, Van Hecke W, Frijlink DW, Wattjes MP (2015): PML in a patient without severe lymphocytopenia receiving dimethyl fumarate. N Engl J Med 372: 1474–1476

    Google Scholar 

  • O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R (2014): Antibiotics and antiseptics for venous leg ulcers. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD003557. DOI: 10.1002/14651858.CD003557.pub5 Palfreyman S, Nelson EA, Michaels JA (2007): Dressings for venous leg ulcers: systematic review and mety-analysis. Br Med J 335: 244–248

    Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group (2005): Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 52: 810–822

    Article  Google Scholar 

  • Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS,

    Google Scholar 

  • Young M, Rittenberg S, Lebwohl MG, Horn EJ, for the Psoriasis Foundation (2007):

    Google Scholar 

  • National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143: 239–242

    Google Scholar 

  • Patel B, Siskin S, Krazmien R, Lebwohl M (1998): Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38: 1010–1011

    Article  CAS  PubMed  Google Scholar 

  • Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, Green J, van der Meijden W, Gomberg M, Moi H; IUSTI/WHO Europe (2011): European guideline for the management of genital herpes, 2010. Int J STD AIDS 22: 1–10

    Article  CAS  PubMed  Google Scholar 

  • Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P,

    Google Scholar 

  • Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009): European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23 (Suppl 2): 1–70

    PubMed  Google Scholar 

  • Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, Woolacott N, Sculpher M (2010): Alitretinoin for the treatment of severe chronic hand eczema. Health Technol Assess; 14 Suppl 1: 39–46

    PubMed  Google Scholar 

  • Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T (2008): Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 158: 801–807

    Article  CAS  PubMed  Google Scholar 

  • Piatkowski A, Drummer N, Andriessen A, Ulrich D, Pallua N (2011): Randomized controlled single center study comparing a polyhexanide containing bio-cellulose dressing with silver sulfadiazine cream in partial-thickness dermal burns. 37: 800–804

    Google Scholar 

  • Post B, Jänner M (1971): Zur Indikation der Gerbstofftherapie in der Dermatologie. Klinische Erfahrungen mit Tannosynt. Ther Ggw 110: 1477–1494

    CAS  PubMed  Google Scholar 

  • Qureshi AA, Fischer MA (2006): Topical calcineurin inhibitors for atopic dermatitis - Balancing clinical benefit and possible risks. Arch Dermatol 142: 633–637

    Article  PubMed  Google Scholar 

  • Rahimi H, Mara T, Costella J, Speechley M, Bohay R (2012): Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 618–627

    Article  PubMed  Google Scholar 

  • Ramos-e-Silva M, Oliveira Lima CM, Casz Schechtman R, Moritz Trope B, Carneiro S (2012): Systemic mycoses in immunodepressed patients (AIDS) Clin Dermatol 30: 616–627

    Article  PubMed  Google Scholar 

  • Rashaan ZM, Krijnen P, Klamer RR, Schipper IB, Dekkers OM, Breederveld RS (2014): Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis. Wound Repair Regen; 22: 473–482

    Article  PubMed  Google Scholar 

  • Rathi SK, D'Souza P (2012): Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol 57: 251–259

    Article  PubMed Central  PubMed  Google Scholar 

  • Ring J, Fröhlich HH (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl, Springer-Verlag, Berlin Heidelberg

    Book  Google Scholar 

  • Rotta I, Sanchez A, Gon^alves PR, Otuki MF, Correr CJ (2012): Efficacy and safety of topical antifun- gals in the treatment of dermatomycosis: a systematic review. Br J Dermatol 166: 927–933

    Article  CAS  PubMed  Google Scholar 

  • Ruzicka T (2006): Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract 60: 85–92

    Article  CAS  PubMed  Google Scholar 

  • Samrao A, Cockerell CJ (2013): Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents. Am J Clin Dermatol 14: 273–237

    Article  PubMed  Google Scholar 

  • Sapijaszko MJA (2005): Imiquimod 5% cream (Aldara ) in the treatment of basal cell carcinoma. Skin Ther Lett 10: 2–5

    CAS  Google Scholar 

  • Schäfer-Korting M, Schmid MH, Korting HC (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385

    Article  PubMed  Google Scholar 

  • Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010): Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39–49

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Schneider LA, Hinrichs R, Scharfetter-Kochanek K (2007): Indikationen zur UVB-Phototherapie. Dtsch Med Wochenschr 132: 888–891

    Article  CAS  PubMed  Google Scholar 

  • Schöfer H, Simonsen L (2010): Fusidic acid in dermatology: an updated review. Eur J Dermatol 20: 6–15

    PubMed  Google Scholar 

  • Schülke & Mayr GmbH (2011): Octenisept - Ödematöse Schwellungen und Gewebeschädigungen nach Wundspülungen unter Druck - Warnung vor nicht bestimmungsgemäßem Gebrauch Rote Hand Brief 21. Januar 2011, http://www.akdae.de/Arzneimittelsicherheit/>RHB/20110127.pdf

  • Schulze-Dirks A, Frosch PJ (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377

    CAS  PubMed  Google Scholar 

  • Shim J, Lanier J, Qui MK (2014): Clinical inquiry: what is the best treatment for impetigo? J Fam Pract; 63: 333–335

    PubMed  Google Scholar 

  • Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR (2011): Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-a inhibitors: The Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol 67: e179–185

    Google Scholar 

  • Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R (2006): Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomaized, double-blind comparison. J Dermatol Treatm 17: 38–44

    Article  CAS  Google Scholar 

  • Singal A, Khanna D (2011): Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol 77: 659–672

    Article  PubMed  Google Scholar 

  • Smith RG (2008): Enzymatic debriding agents: an evaluation of the medical Literature. Ostomy Wound Manage 54: 16–34

    PubMed  Google Scholar 

  • Solares CA, Batra PS, Hall GS, Citardi MJ (2006): Treatment of chronic rhinosinusitis exacer- bations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27: 161–165

    Article  CAS  PubMed  Google Scholar 

  • Stockfleth E, Beti H, Orasan R, Grigorian F, Mescheder A, Tawfik H, Thielert C (2008): Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Br J Dermatol; 158: 1329–1338

    Article  CAS  PubMed  Google Scholar 

  • Stockfleth E, Kerl H, Zwingers T, Willers C (2011): Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histologi- cal and clinical study results. Br J Dermatol; 165: 1101–1108

    Article  CAS  PubMed  Google Scholar 

  • Strömberg HE, Ägren MS (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 111: 461–468

    Article  PubMed  Google Scholar 

  • Subissi A, Monti D, Togni G, Mailland F (2010): Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs 70: 2133–2152

    Article  PubMed  Google Scholar 

  • Sunderkötter C, Herrmann M, Jappe U (2006): Antimikrobielle Therapie in der Dermatologie. J Dtsch Dermatol Ges 4: 10–26

    Article  PubMed  Google Scholar 

  • Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerden B, Bergman U, Jokinen J (2010): Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. Br Med J 341: c5812

    Google Scholar 

  • Swanson N, Abramovits W, Berman B, Kulp J, Rigel DS, Levy S (2010): Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol 62: 582–590

    Article  CAS  PubMed  Google Scholar 

  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA (2009): Topical corticosteroids in dermatology. J Drugs Dermatol 8: 1093–1105

    PubMed  Google Scholar 

  • Tatti S, Swinehart JM, Thielert C, Tawfik H, Mescheder A, Beutner KR (2008): Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Obstet Gynecol; 111: 1371–1379

    Article  PubMed  Google Scholar 

  • Tennis P, Gelfand JM, Rothman KJ (2011): Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165: 465–473

    Article  CAS  PubMed  Google Scholar 

  • Thag D, Schöfer H (2005): Topische Antibiotika zur Therapie von Hautinfektionen. Hautarzt 56: 381–396

    Article  Google Scholar 

  • Thag D, Weisenseel P, Philipp S, Rosenbach T, Rotterdam S, Augustin M, Neureither M, Reich K (2013): Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS). J Dtsch Dermatol Ges 11: 429–435

    Google Scholar 

  • Thielitz A, AbdeL-Naser MB, Fluhr JW, Zouboulis CC, Gollnick H (2010): Topische Retinoide bei Akne - eine evidenzbasierte Übersicht. J Dtsch Dermatol Ges 8 (Suppl 1): S15–23

    PubMed  Google Scholar 

  • Udompataikul M, Limpa-o-vart D (2012): Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study. J Drugs Dermatol 11: 366–374

    CAS  PubMed  Google Scholar 

  • Uter W, Geier J, Fuchs T (2000): Contact allergy to polidocanol, 1992 to 1999. J All Clin Immunol 106: 1203–1204

    Article  CAS  Google Scholar 

  • Valente Duarte de Sousa IC (2014): Novel pharmacological approaches for the treatment of acne vulgaris. Expert Opin Investig Drugs 2: 1–22

    Google Scholar 

  • van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M; International Psoriasis Council (2011): Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol 25: 1130139 van Steensel MAM (2007): Emerging drugs for ichthyosis. Expert Opin Emerg Drugs 12: 647–656

    Google Scholar 

  • van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L (2015): Interventions for

    Google Scholar 

  • rosacea. Cochrane Database Syst Rev. 2015 Apr 28;4:CD00326–2. doi: 10.1002/14651858. CD003262.pub5

    Google Scholar 

  • Vegter S, Tolley K (2014): A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe. PLoS One 2014 Jun 3; 9: e9682–9

    Google Scholar 

  • von Krogh G (1978): Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study. Acta Derm Venereol 58: 163–168

    Google Scholar 

  • Walker F, Adamczyk A, Kellerer C, Belge K, Brück J, Berner T, Merten K, Nunez Gomez N, Neu- reither M, Röcken M, Ghoreschi K; Study group (2014): Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life. Br J Dermatol 171: 1197–1205

    Article  CAS  Google Scholar 

  • Walluf-Blume D (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm Ind 53: 152–158

    Google Scholar 

  • Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W (2006): Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 89: 1654–1658

    PubMed  Google Scholar 

  • Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA (2005): Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled study. J Am Acad Dermatol 53: 578–584

    Article  PubMed  Google Scholar 

  • Wilkinson JD (1998): Fusidic acid in dermatology. Br J Dermatol 139 (Suppl 53): 37–40

    Article  CAS  PubMed  Google Scholar 

  • Williams H (2002): New treatments for topic dermatitis. Brit Med J 324: 1533–1534

    Article  PubMed Central  PubMed  Google Scholar 

  • Williams HC, Dellavalle RP, Garner S (2012): Acne vulgaris. Lancet 379: 361–372

    Article  PubMed  Google Scholar 

  • Wohlrab J (2006): Basistherapie der Psoriasis vulgaris. Hautarzt 57: 661–665

    Article  CAS  PubMed  Google Scholar 

  • Wong RK, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB, Eaby-Sandy B, Lacouture ME (2013): Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer; 21: 2933–2948

    Article  PubMed  Google Scholar 

  • Worret WI, Fluhr JW (2006): Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 4: 293–300

    Article  PubMed  Google Scholar 

  • Wright JB, Lam K, Burrell RE (1998): Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 26: 572–577

    Article  CAS  PubMed  Google Scholar 

  • Yan J, Chen SL, Wang HN, Wu TX (2006): Meta-analysis of 5% imiquimod amd 0,5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 213: 218–223

    Article  CAS  PubMed  Google Scholar 

  • Yin Z, Xu J, Luo D (2011): Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis. J Biomed Res; 25: 385–391

    Google Scholar 

  • Yates JE, Phifer JB, Flake D (2009): Clinical inquiries. Do nonmedicated topicals relieve child- hood eczema? J Fam Pract 58: 280–281

    PubMed  Google Scholar 

Download references

Authors
  1. Judith Günther
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2015 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Günther, J., Fricke, U. (2015). Dermatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2015. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47186-9_21

    Download citation

    • DOI: https://doi.org/10.1007/978-3-662-47186-9_21

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-662-47185-2

    • Online ISBN: 978-3-662-47186-9

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation